The Pakistan Pharmaceutical Manufacturers Association (PPMA) has firmly dismissed recent media claims about shortages of essential medicines in the country. Despite rising fuel prices, the association confirmed that medicine prices have remained stable, regulated by the government.
In a significant development, the PPMA emphasized that essential medicines, including insulin, antibiotics, cardiovascular drugs, anti-hypertensives, anti-diabetics, and vaccines, continue to be supplied without interruption. This assurance comes amid increased freight charges and higher import costs for raw materials due to ongoing regional challenges.
The association highlighted that local drug manufacturers have absorbed considerable cost pressures related to importing active pharmaceutical ingredients and other inputs. They have ensured that production and distribution systems operate smoothly to meet demand nationwide.
Notably, approximately 90 percent of medicines used in Pakistan are produced domestically. The sector currently maintains sufficient stocks of both raw materials and finished products to fulfill the country’s needs.
Meanwhile, the PPMA urged media outlets to exercise caution and refrain from broadcasting or publishing unverified reports. The association warned that sensational or inaccurate information could provoke unnecessary panic, disrupt perceptions of medicine availability, and cause distress among patients dependent on continuous treatment.
